Lipocine's total assets for Q2 2026 were $23.84M, a decrease of -6.01% from the previous quarter. LPCN total liabilities were $2.07M for the fiscal quarter, a -18.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.